Harvey J. Alter

Last updated

Harvey J. Alter
Harvey J Alter 2020.jpg
Alter in 2020
Born
Harvey James Alter

(1935-09-12) September 12, 1935 (age 88)
New York City, New York, U.S.
Education University of Rochester (BA, MD)
National Institute of Health
University of Washington
Georgetown University
Known for Hepatitis C
Awards Karl Landsteiner Memorial Award (1992)
Lasker Award (2000)
Gairdner Foundation International Award (2013)
Nobel Prize for Medicine (2020)
Scientific career
Fields Virology

Harvey James Alter (born September 12, 1935) is an American medical researcher, virologist, physician and Nobel Prize laureate, who is best known for his work that led to the discovery of the hepatitis C virus. [1] Alter is the former chief of the infectious disease section and the associate director for research of the Department of Transfusion Medicine at the Warren Grant Magnuson Clinical Center in the National Institutes of Health (NIH) in Bethesda, Maryland. In the mid-1970s, Alter and his research team demonstrated that most post-transfusion hepatitis cases were not due to hepatitis A or hepatitis B viruses. Working independently, Alter and Edward Tabor, a scientist at the U.S. Food and Drug Administration, proved through transmission studies in chimpanzees that a new form of hepatitis, initially called "non-A, non-B hepatitis" caused the infections, and that the causative agent was probably a virus. This work eventually led to the discovery of the hepatitis C virus in 1988, [1] for which he shared the Nobel Prize in Physiology or Medicine in 2020 along with Michael Houghton and Charles M. Rice. [2] [3]

Contents

Alter has received recognition for the research leading to the discovery of the virus that causes hepatitis C. He was awarded the Distinguished Service Medal, the highest award conferred to civilians in United States government public health service, and the 2000 Albert Lasker Award for Clinical Medical Research. [4] [5]

Early life and education

Alter was born in New York City [6] in a Jewish family. [7] He attended the University of Rochester in Rochester, New York, and earned a Bachelor of Arts degree in 1956. In 1960, Alter obtained a medical degree from University of Rochester [8] [9] and began a residency at Strong Memorial. Alters's post graduate training includes a rotation as a clinical associate at the National Institutes of Health in Bethesda, Maryland, from December 1961 to June 1964; [5] [7] [10] a year of residency in medicine at University of Washington School of Medicine, Seattle, Washington, [11] from July 1964 to June 1965; and work as a hematology fellow at Georgetown University Hospital, Washington, D.C., from July 1965 to June 1966. [5]

Career

Alter has a medical license issued by the District of Columbia. Additionally he holds certification by the American Board of Pathology blood banking subspecialty and is a fellow of the American College of Physicians. [5] Clinical appointments include: director, hematology research at Georgetown University Hospital from July 1966 to June 1969; senior investigator in the Department of Transfusion Medicine at the NIH from July 1969 to present; chief of infectious diseases section at the department of transfusion medicine in the Clinical Center NIH from December 1972 to present; associate director for research at the department of transfusion medicine at the Clinical Center at NIH from January 1987 to present. [5]

Alter's academic appointments include: clinical associate professor of medicine at Georgetown University Hospital; adjunct professor at Southwest Foundation for Biomedical Research in San Antonio, TX; clinical professor of medicine at Georgetown University Hospital; and a faculty position at Clinical Research Training Program at the NIH. [5]

Alter came to the NIH Clinical Center as a senior investigator in 1969. [12] He remains at the NIH as a chief of the infectious diseases section and associate director of research in the department of transfusion medicine. [13]

Medical research

Nobel Prize in Physiology or Medicine 2020: Seminal experiments by HJ Alter, M Houghton and CM Rice leading to the discovery of HCV as the causative agent of non-A, non-B hepatitis. 15 Hegasy Nobel Prize 2020 HepC.jpg
Nobel Prize in Physiology or Medicine 2020: Seminal experiments by HJ Alter, M Houghton and CM Rice leading to the discovery of HCV as the causative agent of non-A, non-B hepatitis.

As a young research fellow in 1964, Alter co-discovered the Australia antigen with Baruch Blumberg. [14] This work was a major factor in isolating the hepatitis B virus. Later, Alter led a Clinical Center project to store blood samples used to uncover the causes and reduce the risk of transfusion-associated hepatitis. Based on his work, the United States started blood and donor screening programs that lowered the cause of hepatitis due to this risk from 30 percent in 1970 to nearly 0. [15]

In the mid-1970s, Alter and his research team demonstrated that most post-transfusion hepatitis cases were not due to hepatitis A and hepatitis B viruses. Work by Alter, in collaboration with Bob Purcell, and work by Edward Tabor working simultaneously in another laboratory, [16] proved through transmission studies in chimpanzees that a new form of hepatitis, initially called "non-A, non-B hepatitis" caused the infections. This work eventually led to the discovery of the hepatitis C virus. In 1988 the new hepatitis virus was confirmed by Alter's group by verifying its presence in their stored panel of NANBH specimens. [17] In April 1989, the discovery of the non-A, non-B virus, renamed hepatitis C virus, was published in two articles in Science. [18] [19] [20]

Honors and awards

Alter in 2000 Dr. Harvey J. Alter (1935- (28926785543).jpg
Alter in 2000

Alter has received recognition for his research including the 2000 Albert Lasker Award for Clinical Medical Research for his work leading to the discovery of the virus that causes hepatitis C. Alter and his co-awardee Michael Houghton were recognized for the development of blood screening methods that essentially eliminated the risk of transfusion-associated hepatitis in the U.S. [4] Other honors for his medical research include the Distinguished Service Medal, the highest award conferred to civilians in United States government public health service. [5] Alter has been elected to both the National Academy of Sciences and the Institute of Medicine. [12] In 2002 he received The International Society of Blood Transfusion Presidential Award. [5] In 2005, he received the American College of Physicians Award for Outstanding Work in Science as Related to Medicine, and the First International Prize of Inserm (the French equivalent of NIH). And in 2019, he's nominated for T. Washington Fellows. [21]

Speaking of Alter's long research career at the time of the 2000 Lasker Award, Harvey Klein, chief of the Clinical Center Transfusion Medicine Department noted, "As a young research fellow, Dr. Alter co-discovered the Australia antigen, a key to detecting Hepatitis B virus. For many investigators that would be the highlight of a career. For Dr. Alter it was only an auspicious beginning." [22]

Alter was awarded Grand Hamdan International Award - Gastroenterology by Hamdan Medical Award in 2016.

Alter was awarded the 2020 Nobel Prize in Physiology or Medicine alongside Michael Houghton and Charles M. Rice for "discoveries that led to the identification of [the] Hepatitis C virus." [2]

Personal life

He married Barbara Bailey; they have two children, Mark, also an MD, and Stacey, a teacher. He is currently married to Diane Dowling and has two step children, Lydia Rodin and Erinn Torres, and nine grandchildren. [7]

See also

Related Research Articles

<span class="mw-page-title-main">Hepatitis C</span> Human viral infection

Hepatitis C is an infectious disease caused by the hepatitis C virus (HCV) that primarily affects the liver; it is a type of viral hepatitis. During the initial infection period, people often have mild or no symptoms. Early symptoms can include fever, dark urine, abdominal pain, and yellow tinged skin. The virus persists in the liver, becoming chronic, in about 70% of those initially infected. Early on, chronic infection typically has no symptoms. Over many years however, it often leads to liver disease and occasionally cirrhosis. In some cases, those with cirrhosis will develop serious complications such as liver failure, liver cancer, or dilated blood vessels in the esophagus and stomach.

<span class="mw-page-title-main">Hepatology</span> Medical specialty

Hepatology is the branch of medicine that incorporates the study of liver, gallbladder, biliary tree, and pancreas as well as management of their disorders. Although traditionally considered a sub-specialty of gastroenterology, rapid expansion has led in some countries to doctors specializing solely on this area, who are called hepatologists.

<span class="mw-page-title-main">Baruch Samuel Blumberg</span> American doctor (1925–2011)

Baruch Samuel Blumberg, known as Barry Blumberg, was an American physician, geneticist, and co-recipient of the 1976 Nobel Prize in Physiology or Medicine, for his work on the hepatitis B virus while an investigator at the NIH and at the Fox Chase Cancer Center. He was president of the American Philosophical Society from 2005 until his death.

<span class="mw-page-title-main">Harold E. Varmus</span> American scientist (born 1939)

Harold Eliot Varmus is an American Nobel Prize-winning scientist. He is currently the Lewis Thomas University Professor of Medicine at Weill Cornell Medicine and a senior associate at the New York Genome Center.

<span class="mw-page-title-main">Joseph L. Goldstein</span> American biochemist

Joseph Leonard Goldstein ForMemRS is an American biochemist. He received the Nobel Prize in Physiology or Medicine in 1985, along with fellow University of Texas Southwestern researcher, Michael Brown, for their studies regarding cholesterol. They discovered that human cells have low-density lipoprotein (LDL) receptors that remove cholesterol from the blood and that when LDL receptors are not present in sufficient numbers, individuals develop hypercholesterolemia and become at risk for cholesterol related diseases, notably coronary heart disease. Their studies led to the development of statin drugs.

Fox Chase Cancer Center is a National Cancer Institute-designated Comprehensive Cancer Center research facility and hospital located in the Fox Chase section of Philadelphia, Pennsylvania, United States. The main facilities of the center are located on property adjoining Burholme Park. The center is part of the Temple University Health System (TUHS) and specializes in the treatment and prevention of cancer.

<span class="mw-page-title-main">Francis Peyton Rous</span> American scientist (1879–1970)

Francis Peyton Rous was an American pathologist at the Rockefeller University known for his works in oncoviruses, blood transfusion and physiology of digestion. A medical graduate from the Johns Hopkins University, he was discouraged to become a practicing physician due to severe tuberculosis. After three years of working as an instructor of pathology at the University of Michigan, he became dedicated researcher at the Rockefeller Institute for Medical Research for the rest of his career.

<span class="mw-page-title-main">University of Virginia School of Medicine</span>

The University of Virginia School of Medicine is the graduate medical school of the University of Virginia. The school's facilities are on the University of Virginia grounds adjacent to Academical Village in Charlottesville, Virginia. Founded in 1819 by Thomas Jefferson, UVA SoM is the tenth oldest medical school in the United States. The School of Medicine confers Doctor of Medicine (M.D.) and Doctor of Philosophy (PhD) degrees, and is closely associated with both the University of Virginia Health System and Inova Health System.

<span class="mw-page-title-main">Lankenau Institute for Medical Research</span>

Lankenau Institute for Medical Research (LIMR), founded in 1927, is a nonprofit, biomedical research institute located on the campus of Lankenau Medical Center in Wynnewood, Pennsylvania, serving as the research division of the Main Line Health System in suburban Philadelphia. LIMR focuses on studies of cancer, cardiovascular, autoimmune, gastrointestinal and other diseases. It houses a center for population health research.

<span class="mw-page-title-main">Robert Gallo</span> American biomedical researcher

Robert Charles Gallo is an American biomedical researcher. He is best known for his role in establishing the human immunodeficiency virus (HIV) as the infectious agent responsible for acquired immune deficiency syndrome (AIDS) and in the development of the HIV blood test, and he has been a major contributor to subsequent HIV research.

<span class="mw-page-title-main">NIH Intramural Research Program</span> Internal research program of the National Institutes of Health

The NIH Intramural Research Program (IRP) is the internal research program of the National Institutes of Health (NIH), known for its synergistic approach to biomedical science. With 1,200 Principal Investigators and over 4,000 Postdoctoral Fellows conducting basic, translational, and clinical research, the NIH Intramural Research Program is the largest biomedical research institution on earth. The unique funding environment of the IRP facilitates opportunities to conduct both long-term and high-impact science that would otherwise be difficult to undertake. With rigorous external reviews ensuring that only the most outstanding research secures funding, the IRP is responsible for many scientific accomplishments, including the discovery of fluoride to prevent tooth decay, the use of lithium to manage bipolar disorder, and the creation of vaccines against hepatitis, Hemophilus influenzae (Hib), and human papillomavirus (HPV). In addition, the IRP has also produced or trained 21 Nobel Prize-winning scientists.

Robert Palmer Beasley was a physician, public health educator and epidemiologist whose work on hepatitis B involved extensive investigations in Taiwan. That work established that hepatitis B virus (HBV) is a primary cause of liver cancer and that hepatitis B virus is transmitted from mother to infant during childbirth. Beasley and his colleagues also proved that HBV mother-to-infant transmission is preventable by at-birth vaccination. Due to this work, the World Health Assembly designated HBV as the seventh global vaccine in 1992. He later became the author of HBV immunization policies for the World Health Organization.

<span class="mw-page-title-main">Michael Houghton</span> British virologist (born 1949)

Sir Michael Houghton is a British scientist and Nobel Prize laureate. Along with Qui-Lim Choo, George Kuo and Daniel W. Bradley, he co-discovered Hepatitis C in 1989. He also co-discovered the Hepatitis D genome in 1986. The discovery of the Hepatitis C virus (HCV) led to the rapid development of diagnostic reagents to detect HCV in blood supplies, which has reduced the risk of acquiring HCV through blood transfusion from one in three to about one in two million. It is estimated that antibody testing has prevented at least 40,000 new infections per year in the US alone and many more worldwide.

Qui-Lim Choo is a Singapore-born scientist, who along with Michael Houghton, George Kuo and Daniel W. Bradley, co-discovered and cloned Hepatitis C in 1989. He also co-discovered the Hepatitis D genome in 1986. The discovery of Hepatitis C led to the rapid development of diagnostic reagents to detect Hepatitis C virus in blood supplies which has reduced the risk of acquiring hepatitis C through blood transfusion from one in three to about one in two million. It is estimated that antibody testing has prevented at least 40,000 new infections per year in the US alone and many more worldwide.

Alton Ivan Sutnick is an American medical researcher, educator and administrator. He is the author of over 200 scholarly publications.

George Ching-Hung Kuo is a Taiwanese-born scientist, who along with Michael Houghton, Qui-Lim Choo and Daniel W. Bradley, co-discovered and cloned the hepatitis C virus in 1989.

<span class="mw-page-title-main">Charles M. Rice</span> American virologist

Charles Moen Rice is an American virologist and Nobel Prize laureate whose main area of research is the hepatitis C virus. He is a professor of virology at the Rockefeller University in New York City and an adjunct professor at Cornell University and Washington University School of Medicine. At the time of the award he was a faculty at Rockefeller.

<span class="mw-page-title-main">William Kaelin Jr.</span> American Nobel Laureate, Professor of Medicine at Harvard University

William G. Kaelin Jr. is an American Nobel laureate physician-scientist. He is a professor of medicine at Harvard University and the Dana–Farber Cancer Institute. His laboratory studies tumor suppressor proteins. In 2016, Kaelin received the Albert Lasker Award for Basic Medical Research and the AACR Princess Takamatsu Award. He also won the Nobel Prize in Physiology or Medicine in 2019 along with Peter J. Ratcliffe and Gregg L. Semenza.

Michael J. Sofia is a chemist whose main research focus is hepatitis C virus and hepatitis B virus drug discovery. He was a co-recipient of the Lasker-DeBakey Clinical Medical Research Award for his work on hepatitis C in 2016 and of the Gertrude B. Elion Memorial Award from the International Society for Antiviral Research in 2017.

The 2020 Nobel Prize in Physiology or Medicine was awarded to the American virologists Harvey J. Alter, Michael Houghton and Charles M. Rice "for the discovery of Hepatitis C virus." During the award ceremony on December 10, 2020, Prof. Gunilla Karlsson-Hedestam said:

"The discovery of the Hepatitis C virus by this year’s Laureates laid the foundation for our current understanding about how the virus survives in its niche during the long chronic phase of the infection, and how liver disease develops. And importantly, it led to the development of highly effective anti-viral medicines that now cure the infection in almost all treated persons."

References

  1. 1 2 McHenry Harris; Randall E. Harris (2013). Epidemiology of Chronic Disease. Jones & Bartlett Publishers. ISBN   978-0-7637-8047-0.
  2. 1 2 "Press release: The Nobel Prize in Physiology or Medicine 2020". Nobel Foundation. Retrieved October 5, 2020.
  3. ↑ Wu, Katherine J.; Victor, Daniel (October 5, 2020). "Nobel Prize in Medicine Awarded to Scientists Who Discovered Hepatitis C Virus - Harvey J. Alter, Michael Houghton and Charles M. Rice were jointly honored for their decisive contribution to the fight against blood-borne hepatitis, a major global health problem". The New York Times . Retrieved October 6, 2020.
  4. 1 2 "The Lasker Foundation". Archived from the original on February 25, 2008.
  5. 1 2 3 4 5 6 7 8 "Harvey J. Alter Curriculum Vitae". Archived from the original on September 4, 2005. Retrieved April 21, 2006.
  6. ↑ Henrichsen, Colleen (September 21, 2000). "NIH Clinical Center scientist a Lasker Award recipient". Press release. NIH. Retrieved October 20, 2009.
  7. 1 2 3 Alter, Harvey J. (2014). "The road not taken or how I learned to love the liver: A personal perspective on hepatitis history". Hepatology. 59 (1): 4–12. doi: 10.1002/hep.26787 . ISSN   1527-3350. PMID   24123147. S2CID   30040670.
  8. ↑ "Rochester graduate awarded 2020 Nobel Prize for 'landmark achievement' against hepatitis". NewsCenter. October 5, 2020. Retrieved October 5, 2020.
  9. ↑ Freile, Victoria E. (October 6, 2020). "UR graduate Harvey Alter awarded Nobel Prize in fight against Hepatitis". Democrat and Chronicle. Retrieved October 6, 2020.
  10. ↑ National Institutes of Health (U.S.). Clinical Center (1958). Report of program activities : National Institutes of Health. Clinical Center. NIH Library. Bethesda, Md. : The Center.
  11. ↑ Alter, Harvey J.; Klein, Harvey G. (October 1, 2008). "The hazards of blood transfusion in historical perspective". Blood. 112 (7): 2617–2626. doi:10.1182/blood-2008-07-077370. ISSN   0006-4971. PMC   2962447 . PMID   18809775.
  12. 1 2 "Principal Investigators". NIH Intramural Research Program. Retrieved October 5, 2020.
  13. ↑ "Jewish Physician Among Winners Of Nobel Prize For Medicine". Voz Iz Neias. October 5, 2020. Retrieved October 6, 2020.
  14. ↑ "The NIH Almanac". Department of Health and Human Services. National Institutes of Health. June 4, 2009. Retrieved October 20, 2009.
  15. ↑ "2005 NIH profile". Archived from the original on March 29, 2006. Retrieved April 21, 2006.
  16. ↑ Tabor, E.; et al. (1978). "Transmission of non A, non B hepatitis from man to chimpanzees". The Lancet . 311 (8062): 463–466. doi:10.1016/S0140-6736(78)90132-0. PMID   76018. S2CID   27675695.
  17. ↑ "Alter.pdf" (PDF). Archived from the original (PDF) on September 27, 2007.
  18. ↑ Abdel-Ghaffar, Tawhida Y; Sira, Mostafa M; El Naghi, Suzan (December 8, 2015). "Hepatitis C genotype 4: The past, present, and future". World Journal of Hepatology. 7 (28): 2792–2810. doi: 10.4254/wjh.v7.i28.2792 . ISSN   1948-5182. PMC   4670951 . PMID   26668691.
  19. ↑ Kuo, G.; Choo, Q. L.; Alter, H. J.; Gitnick, G. L. (1989). "An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis". Science . 244 (1989 Apr 21, 244(4902):362-4): 362–4. Bibcode:1989Sci...244..362K. doi:10.1126/science.2496467. PMID   2496467.
  20. ↑ Choo, Q. L.; Kuo, G; Weiner, A. J.; Overby, L. R. (1989). "Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome". Science. 244 (1989 Apr 21, 244(4902):359-62): 359–62. Bibcode:1989Sci...244..359C. doi:10.1126/science.2523562. PMID   2523562.
  21. ↑ "Prof. Harvey J Alter". Sheikh Hamdan Bin Rashid Al Maktoum Award for Medical Sciences. Retrieved October 6, 2020.
  22. ↑ "Clinical Center News October 2000". Archived from the original on November 30, 2006. Retrieved April 21, 2006.

Further reading

This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.